Finland· FI-REL-REL6072
Ercoquin
A hydroxychloroquine product, registered in Finland by Orion Pharma A/S. The same ATC class is registered in 17 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Hydroxychloroquine is registered in 17 of 19 countries.
Countries holding a registration under ATC P01BA02 (hydroxychloroquine), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 10 of them publish a price we can compare per daily dose
Hydroxychloroquine · ATC P01BA02
17 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Ireland
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of hydroxychloroquine costs, country by country.
Normalised to the WHO defined daily dose (0.516 g), the median price runs from $0.33 in France to $1.28 in Switzerland — a ×3.9 gap.
- 3 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Hydroxychloroquine · price per daily dose (0.516 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.28
- IT Italy$0.45
- FR France$0.33
The record
At a glance
Fimea (Finland)- Manufacturer
- Orion Pharma A/S
- Country
- Finland (FI)
- ATC code
- P01BA02
- ATC class
- Hydroxychloroquine
- Defined daily dose
- 0.516 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
748 interactions on record for hydroxychloroquine.
Graded by severity as the source publishes them — 220 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Hydroxychloroquine · interactions on record
748 records
- 220 severe
- 278 moderate
- 6 minor
- 244 info
Most severe, free to view
- PapaverineA03AD01severe
- CisaprideA03FA02severe
- OndansetronA04AA01severe
- GranisetronA04AA02severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under P01BA02
Hydroxychloroquine, as other registers publish it.
- CanadaAPO-HYDROXYQUINEAPOTEX INC
- PolandAutokilaTarchomińskie Zakłady Farmaceutyczne "Polfa" S.A.
- PolandHydroqueninAflofarm Farmacja Polska Sp. z o.o.
- NorwayHydroxychloroquinAristo Pharma GmbH
- GermanyHydroxychloroquin AristoAristo Pharma Gmbh (Art 57)
- GermanyHydroxychloroquin HeumannHeumann Pharma Gmbh & Co. Generica Kg
- GermanyHydroxychloroquin IpcaIpca Productos Farmaceuticos Unipessoal Lda
- GermanyHydroxychloroquin RatiopharmRatiopharm Gmbh
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/153116df-0437-408b-863d-88e9cf918ece GET /v1/drugs/153116df-0437-408b-863d-88e9cf918ece?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.516",
"form": "tabletti",
"route": null,
"ddd_unit": "g",
"strength": "250 mg",
"atc_label": "hydroksiklorokiini",
"ma_number": "5151",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL6072",
"authorised_at": "1968-01-03"
}See everything about hydroxychloroquine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.